Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 2/20 | 0.51 |
| ▸ | RXRA | P19793 | 2/20 | 0.43 |
| ▸ | RXRB | P28702 | 2/20 | 0.43 |
| ▸ | SYK | P43405 | 2/20 | 0.43 |
| ▸ | ASIC3 | Q9UHC3 | 2/20 | 0.42 |
| ▸ | KMO | O15229 | 2/20 | 0.42 |
| ▸ | DHODH | Q02127 | 1/20 | 0.40 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.38 |
| ▸ | METAP2 | P50579 | 1/20 | 0.37 |
| ▸ | MAPKAPK2 | P49137 | 2/20 | 0.36 |
| ▸ | CTSA | P10619 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29663840 | 1.00 | KIF11 (0.51) | KIF11RXRARXRBSYKASIC3 | |
| SCHEMBL28790717 | 1.00 | KIF11 (0.51) | KIF11RXRARXRBSYKASIC3 | |
| SCHEMBL2481424 | 0.98 | KIF11 (0.53) | KIF11RXRARXRBSYKASIC3 | |
| SCHEMBL15263772 | 0.97 | KIF11 (0.51) | KIF11RXRARXRBSYKASIC3 | |
| SCHEMBL30416106 | 0.97 | KIF11 (0.51) | KIF11RXRARXRBSYKASIC3 | |
| SCHEMBL15991694 | 0.97 | KIF11 (0.51) | KIF11RXRARXRBSYKASIC3 | |
| SCHEMBL15279893 | 0.97 | KIF11 (0.51) | KIF11RXRARXRBSYKASIC3 | |
| SCHEMBL30182884 | 0.97 | KIF11 (0.51) | KIF11RXRARXRBSYKASIC3 | |
| SCHEMBL26471845 | 0.92 | KIF11 (0.50) | KIF11RXRARXRBASIC3KMO | |
| SCHEMBL18695526 | 0.90 | ASIC3 (0.52) | KIF11ASIC3METAP2MAPKAPK2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 166 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240244957-A1 | FORMULATION OF AN ORGANIC FUNCTIONAL MATERIAL | Merck Patent KGaA (DE) | 2024-07-18 | — | — | US | disclosed |
| CN-117730638-A | Printing method by combining inks | 默克专利有限公司 | 2024-03-19 | — | — | CN | disclosed |
| CN-117178031-A | Preparation of organic functional material | 默克专利有限公司 | 2023-12-05 | — | — | CN | disclosed |
| EP-3475372-B1 | FORMULATION OF AN ORGANIC FUNCTIONAL MATERIAL | MERCK PATENT GMBH (DE) | 2023-11-22 | — | — | EP | disclosed |
| EP-3387077-B1 | FORMULATIONS CONTAINING KETONES COMPRISING NON-AROMATIC CYCLES | MERCK PATENT GMBH (DE) | 2023-10-18 | — | — | EP | disclosed |
| US-11770971-B2 | Esters containing aromatic groups as solvents for organic electronic formulations | MERCK PATENT GMBH (DE) | 2023-09-26 | — | — | US | disclosed |
| CN-116635491-A | Ink system and method for inkjet printing | 默克专利有限公司 | 2023-08-22 | — | — | CN | disclosed |
| CN-110168047-B | Preparation of organic functional material | 默克专利有限公司 | 2023-08-08 | — | — | CN | disclosed |
| CN-110892543-B | Preparation of organic functional material | 默克专利有限公司 | 2023-07-28 | — | — | CN | disclosed |
| EP-3807367-B1 | FORMULATION OF AN ORGANIC FUNCTIONAL MATERIAL | MERCK PATENT GMBH (DE) | 2023-07-19 | — | — | EP | disclosed |
| US-20120245658-A1 | Therapeutic and Cosmetic Electroluminescent Compositions | MERCK PATENT GMBH (DE) | 2012-09-27 | — | — | US | disclosed |
| US-20120238105-A1 | FORMULATIONS FOR THE PRODUCTION OF ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2012-09-20 | — | — | US | disclosed |
| US-20120132898-A1 | ELECTRONIC DEVICES COMPRISING MULTI CYCLIC HYDROCARBONS | MERCK PATENT GMBH (DE) | 2012-05-31 | — | — | US | disclosed |
| US-20120107989-A1 | CROSS-LINKABLE IRIDIUM COMPLEXES AND ORGANIC LIGHT-EMITTING DEVICES USING THE SAME | UNIVERSAL DISPLAY CORPORATION | 2012-05-03 | — | — | US | disclosed |
| US-8119255-B2 | First and second electrode; a first organic layer between the electrodes; the first organic layer is a non-electroluminescent, cross-linked metal complex; and a second organic layer is an emissive electroluminescent organic material | UNIVERSAL DISPLAY CORPORATION (US) | 2012-02-21 | — | — | US | disclosed |
| US-20110105778-A1 | Materials for Organic Electroluminescence Devices | MERCK PATENT GMBH (DE) | 2011-05-05 | — | — | US | disclosed |
| US-7825587-B2 | Charge transporting layer for organic electroluminescent device | UNIVERSAL DISPLAY CORPORATION (US) | 2010-11-02 | — | — | US | disclosed |
| US-20080220265-A1 | Cross-linkable Iridium Complexes and Organic Light-Emitting Devices Using the Same | UNIVERSAL DISPLAY CORPORATION (US) | 2008-09-11 | — | — | US | disclosed |
| WO-2008073440-A2 | CROSS-LINKABLE IRIDIUM COMPLEXES AND ORGANIC LIGHT-EMITTING DEVICES USING THE SAME | UNIVERSAL DISPLAY CORPORATION (US) | 2008-06-19 | — | — | WO | disclosed |
| US-20080054783-A1 | Cross-linked host materials in organic devices | UNIVERSAL DISPLAY CORP. (US) | 2008-03-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120238105-A1 | FORMULATIONS FOR THE PRODUCTION OF ELECTRONIC DEVICES | NR3C2, KCNE1, KCNJ2 | KIF11 1249/4885RXRA 2810/4885RXRB 2278/4885 |
| US-20080220265-A1 | Cross-linkable Iridium Complexes and Organic Light-Emitting Devices Using the Same | MTCL3, LIG4, L1CAM | KIF11 2377/4885RXRA 1430/4885RXRB 2062/4885 |
| US-20110105778-A1 | Materials for Organic Electroluminescence Devices | L1CAM, EPCAM, GPX1 | KIF11 2945/4885RXRA 4143/4885RXRB 4207/4885 |
| US-20120107989-A1 | CROSS-LINKABLE IRIDIUM COMPLEXES AND ORGANIC LIGHT-EMITTING DEVICES USING THE SAME | MTCL3, LIG4, L1CAM | KIF11 2377/4885RXRA 1430/4885RXRB 2062/4885 |
| US-20120245658-A1 | Therapeutic and Cosmetic Electroluminescent Compositions | LPO, TYR, GPX1 | KIF11 3829/4885RXRA 220/4885RXRB 410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.